HIGHLIGHTS
- who: Kei Ito et al. from the Division of Radiation Oncology, Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Honkomagome, Bunkyo-ku, Tokyo, Japan Department of Radiological Sciences, Komazawa University, Komazawa, Setagaya-ku have published the research work: Palliative Efficacy of High-Dose Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Painful Non-Spine Bone Metastases: A Propensity Score-Matched Analysis, in the Journal: Cancers 2022, 4014 of 19/08/2022
- what: The CR rate of SBRT increased thereafter to more than 50%, and this analysis showed a significant difference, favoring SBRT . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.